Margrethe Bang Henriksen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Margrethe Bang Henriksen has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Lars Henrik Jensen
Department of Oncology, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark
6 shared publications - Ole Hilberg
Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
6 shared publications Claus Lohman Brasen
Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
5 shared publicationsOle Hilberg
Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; Department of Internal Medicine, Vejle University Hospital, Vejle, Denmark
5 shared publicationsTorben Frøstrup Hansen
Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
5 shared publicationsAli Ebrahimi
SDU Health Informatics and Technology, The Mærsk Mc-Kinney Møller Institute, University of Southern Denmark, Odense, Denmark
4 shared publications
Latest Publications
- 23 September 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 27 (2) , 199-200
Response to Letter to the Editor
- 23 September 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 27 (2) , 199-200
Response to Letter to the Editor
- Open Access
- 9 July 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (1) , 176-183
Educational attainment and employment status in lung cancer patients: a nationwide study
Purpose: Lung cancer remains the leading cause of cancer-related deaths globally, with low-dose computed tomography (LDCT) screening widely implemented in several countries. However, current screening eligibility, based largely on the National Lung Cancer Screening Trial and NELSON trial outcomes, does not account for socioeconomic risk factors such as education and employment status, which may impact lung cancer incidence and outcomes. Methods and patients: This study used data from the Danish National Patient Register to examine educational attainment and employment status among 109,940 lung cancer patients diagnosed between 1994 and 2018, compared to a randomly selected matched general population cohort. Results and conclusions: Patients were less likely to hold higher education degrees and more likely to be on disability pension compared to controls, underscoring a significant socioeconomic disparity. Lung cancer patients frequently had only primary school education, with this educational gap widening over time. Employment disparities were also noted, with lung cancer patients twice as likely to be on disability benefits. These findings suggest that socioeconomic vulnerabilities, including educational level and employment, may exacerbate lung cancer risk, possibly linked to higher smoking prevalence and occupational carcinogen exposure in lower socioeconomic groups. Targeted public health initiatives focusing on smoking cessation and LDCT access for socioeconomically disadvantaged individuals are crucial for addressing these disparities and improving lung cancer outcomes. National wealth alone appears insufficient in bridging these socioeconomic gaps, emphasizing the need for strategic, targeted interventions in lung cancer prevention and early detection.
- 9 July 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (1) , 176-183
Open AccessEducational attainment and employment status in lung cancer patients: a nationwide study
Purpose: Lung cancer remains the leading cause of cancer-related deaths globally, with low-dose computed tomography (LDCT) screening widely implemented in several countries. However, current screening eligibility, based largely on the National Lung Cancer Screening Trial and NELSON trial outcomes, does not account for socioeconomic risk factors such as education and employment status, which may impact lung cancer incidence and outcomes. Methods and patients: This study used data from the Danish National Patient Register to examine educational attainment and employment status among 109,940 lung cancer patients diagnosed between 1994 and 2018, compared to a randomly selected matched general population cohort. Results and conclusions: Patients were less likely to hold higher education degrees and more likely to be on disability pension compared to controls, underscoring a significant socioeconomic disparity. Lung cancer patients frequently had only primary school education, with this educational gap widening over time. Employment disparities were also noted, with lung cancer patients twice as likely to be on disability benefits. These findings suggest that socioeconomic vulnerabilities, including educational level and employment, may exacerbate lung cancer risk, possibly linked to higher smoking prevalence and occupational carcinogen exposure in lower socioeconomic groups. Targeted public health initiatives focusing on smoking cessation and LDCT access for socioeconomically disadvantaged individuals are crucial for addressing these disparities and improving lung cancer outcomes. National wealth alone appears insufficient in bridging these socioeconomic gaps, emphasizing the need for strategic, targeted interventions in lung cancer prevention and early detection.
- 22 June 2025
- Published by Springer Nature
- p. 384-388
Explainable AI for Smoking Behaviour Detection: A Danish Medical Records Study
- 22 June 2025
- Published by Springer Nature
- p. 384-388
Explainable AI for Smoking Behaviour Detection: A Danish Medical Records Study
- Open Access
- 4 June 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 26 (6) , 520-525
Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag
- 4 June 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 26 (6) , 520-525
Open AccessMaximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag
- Open Access
- 31 January 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (3) , e70458
Lung Cancer Detection Using Bayesian Networks: A Retrospective Development and Validation Study on a Danish Population of High‐Risk Individuals
Background: Lung cancer (LC) is the top cause of cancer deaths globally, prompting many countries to adopt LC screening programs. While screening typically relies on age and smoking intensity, more efficient risk models exist. We devised a Bayesian network (BN) for LC detection, testing its resilience with varying degrees of missing data and comparing it to a prior machine learning (ML) model.Methods: We analyzed data from 9940 patients referred for LC assessment in Southern Denmark from 2009 to 2018. Variables included age, sex, smoking, and lab results. Our experiments varied missing data (0%–30%), BN structure (expert‐based vs. data‐driven), and discretization method (standard vs. data‐driven).Results: Across all missing data levels, area under the curve (AUC) remained steady, ranging from 0.737 to 0.757, compared to the ML model's AUC of 0.77. BN structure and discretization method had minimal impact on performance. BNs were well calibrated overall, with a net benefit in decision curve analysis when predicted risk exceeded 5%.Conclusion: BN models showed resilience with up to 30% missing values. Moreover, these BNs exhibited similar performance, calibration, and clinical utility compared to the machine learning model developed using the same dataset. Considering their effectiveness in handling missing data, BNs emerge as a relevant method for the development of future lung cancer detection models.
- 31 January 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (3) , e70458
Open AccessLung Cancer Detection Using Bayesian Networks: A Retrospective Development and Validation Study on a Danish Population of High‐Risk Individuals
Background: Lung cancer (LC) is the top cause of cancer deaths globally, prompting many countries to adopt LC screening programs. While screening typically relies on age and smoking intensity, more efficient risk models exist. We devised a Bayesian network (BN) for LC detection, testing its resilience with varying degrees of missing data and comparing it to a prior machine learning (ML) model.Methods: We analyzed data from 9940 patients referred for LC assessment in Southern Denmark from 2009 to 2018. Variables included age, sex, smoking, and lab results. Our experiments varied missing data (0%–30%), BN structure (expert‐based vs. data‐driven), and discretization method (standard vs. data‐driven).Results: Across all missing data levels, area under the curve (AUC) remained steady, ranging from 0.737 to 0.757, compared to the ML model's AUC of 0.77. BN structure and discretization method had minimal impact on performance. BNs were well calibrated overall, with a net benefit in decision curve analysis when predicted risk exceeded 5%.Conclusion: BN models showed resilience with up to 30% missing values. Moreover, these BNs exhibited similar performance, calibration, and clinical utility compared to the machine learning model developed using the same dataset. Considering their effectiveness in handling missing data, BNs emerge as a relevant method for the development of future lung cancer detection models.
- Open Access
- 24 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Pulmonologists-level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach
Lung cancer (LC) remains the primary cause of cancer-related mortality, largely due to late-stage diagnoses. Effective strategies for early detection are therefore of paramount importance. In recent years, machine learning (ML) has demonstrated considerable potential in healthcare by facilitating the detection of various diseases. In this retrospective development and validation study, we developed an ML model based on dynamic ensemble selection (DES) for LC detection. The model leverages standard blood sample analysis and smoking history data from a large population at risk in Denmark. The study includes all patients examined on suspicion of LC in the Region of Southern Denmark from 2009 to 2018. We validated and compared the predictions by the DES model with diagnoses provided by five pulmonologists. Among the 38,944 patients, 9,940 had complete data of which 2,505 (25%) had LC. The DES model achieved an area under the roc curve of 0.77±0.01, sensitivity of 76.2%±2.04%, specificity of 63.8%±2.3%, positive predictive value of 41.6%±1.2%, and F1-score of 53.8%±1.0%. The DES model outperformed all five pulmonologists, achieving a sensitivity 6.5% higher than their average. The model identified smoking status, lactate dehydrogenase, age, total calcium levels, low values of sodium, leucocytes, neutrophil count, and C-reactive protein as the most important factors for LC detection. The results highlight the successful application of the ML approach in detecting LC, surpassing pulmonologists’ performance. Incorporating clinical and laboratory data in future risk assessment models can improve decision-making and facilitate timely referrals.
- 24 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessPulmonologists-level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach
Lung cancer (LC) remains the primary cause of cancer-related mortality, largely due to late-stage diagnoses. Effective strategies for early detection are therefore of paramount importance. In recent years, machine learning (ML) has demonstrated considerable potential in healthcare by facilitating the detection of various diseases. In this retrospective development and validation study, we developed an ML model based on dynamic ensemble selection (DES) for LC detection. The model leverages standard blood sample analysis and smoking history data from a large population at risk in Denmark. The study includes all patients examined on suspicion of LC in the Region of Southern Denmark from 2009 to 2018. We validated and compared the predictions by the DES model with diagnoses provided by five pulmonologists. Among the 38,944 patients, 9,940 had complete data of which 2,505 (25%) had LC. The DES model achieved an area under the roc curve of 0.77±0.01, sensitivity of 76.2%±2.04%, specificity of 63.8%±2.3%, positive predictive value of 41.6%±1.2%, and F1-score of 53.8%±1.0%. The DES model outperformed all five pulmonologists, achieving a sensitivity 6.5% higher than their average. The model identified smoking status, lactate dehydrogenase, age, total calcium levels, low values of sodium, leucocytes, neutrophil count, and C-reactive protein as the most important factors for LC detection. The results highlight the successful application of the ML approach in detecting LC, surpassing pulmonologists’ performance. Incorporating clinical and laboratory data in future risk assessment models can improve decision-making and facilitate timely referrals.
- Open Access
A Bayesian Network Approach to Lung Cancer Screening: Assessing the Impact of Data Quantity, Quality, and the Combination of Data from Danish Electronic Health Records
Background/Objectives: Lung cancer (LC) is the leading cause of cancer mortality, making early diagnosis essential. While LC screening trials are underway globally, optimal prediction models and inclusion criteria are still lacking. This study aimed to develop and evaluate Bayesian Network (BN) models for LC risk prediction using a decade of data from Denmark. The primary goal was to assess BN performance on datasets varying in size and completeness, simulate real-world screening scenarios, and identify the most valuable data sources for LC screening. Methods: The study included 38,944 patients evaluated for LC, with 11,284 (29%) diagnosed. Data on comorbidities, medications, and general practice were available for the entire cohort, while laboratory results, smoking habits, and other variables were only available for subsets. The cohort was divided into four subsets based on data availability, and BNs were trained and validated across these subsets using cross-validation and external validation. To determine the optimal combination of variables, all possible data combinations were evaluated on the samples that contained all the variables (n = 5587). Results: A model trained on the small, complete dataset (AUC 0.78) performed similarly on a larger dataset with 21% missing data (AUC 0.78). Performance dropped when 39% of data were missing (AUC 0.67), resulting in informative variables missing completely in the dataset. Laboratory results and smoking data were the most informative, significantly outperforming models based only on age and smoking status (AUC 0.70). Conclusions: BN models demonstrated moderate to strong predictive performance, even with incomplete data, highlighting the potential value of incorporating laboratory results in LC screening programs.
Open AccessA Bayesian Network Approach to Lung Cancer Screening: Assessing the Impact of Data Quantity, Quality, and the Combination of Data from Danish Electronic Health Records
Background/Objectives: Lung cancer (LC) is the leading cause of cancer mortality, making early diagnosis essential. While LC screening trials are underway globally, optimal prediction models and inclusion criteria are still lacking. This study aimed to develop and evaluate Bayesian Network (BN) models for LC risk prediction using a decade of data from Denmark. The primary goal was to assess BN performance on datasets varying in size and completeness, simulate real-world screening scenarios, and identify the most valuable data sources for LC screening. Methods: The study included 38,944 patients evaluated for LC, with 11,284 (29%) diagnosed. Data on comorbidities, medications, and general practice were available for the entire cohort, while laboratory results, smoking habits, and other variables were only available for subsets. The cohort was divided into four subsets based on data availability, and BNs were trained and validated across these subsets using cross-validation and external validation. To determine the optimal combination of variables, all possible data combinations were evaluated on the samples that contained all the variables (n = 5587). Results: A model trained on the small, complete dataset (AUC 0.78) performed similarly on a larger dataset with 21% missing data (AUC 0.78). Performance dropped when 39% of data were missing (AUC 0.67), resulting in informative variables missing completely in the dataset. Laboratory results and smoking data were the most informative, significantly outperforming models based only on age and smoking status (AUC 0.70). Conclusions: BN models demonstrated moderate to strong predictive performance, even with incomplete data, highlighting the potential value of incorporating laboratory results in LC screening programs.
- Open Access
- 28 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Lung cancer among outpatients with COPD: a 7-year cohort study
Introduction: Lung cancer (LC) is the most common cause of cancer-related deaths worldwide, and its prognosis upon metastasis remains poor. Patients with COPD face a significantly elevated LC risk, up to six times greater than those with normal lung function. We aimed to investigate LC prevalence and stage distribution among COPD outpatients. Furthermore, we aimed to outline the COPD-related variables associated with referral for LC examination.Methods: We conducted a retrospective analysis encompassing the period from 1 January 2012 to 31 December 2018 on all outpatients with COPD and LC and individuals referred for LC examinations.Results: Among all COPD outpatients, 2231 patients (18%) were referred for LC examinations and 565 (4.6%) were diagnosed with LC. LC patients with COPD were more likely to be stage I–II, in contrast to the non-COPD LC population (46%versus26%, p2) and experienced a greater frequency of exacerbations (30%versus24% with two or more exacerbations).Conclusion: Our study revealed a notably high LC incidence among COPD outpatients. LC patients with COPD were diagnosed at earlier stages, and outpatients with more pronounced COPD symptoms were more inclined to undergo LC diagnostics. The overrepresentation of LC cases among COPD outpatients emphasises the importance of tailoring specific screening initiatives for this demographic.
- 28 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Open AccessLung cancer among outpatients with COPD: a 7-year cohort study
Introduction: Lung cancer (LC) is the most common cause of cancer-related deaths worldwide, and its prognosis upon metastasis remains poor. Patients with COPD face a significantly elevated LC risk, up to six times greater than those with normal lung function. We aimed to investigate LC prevalence and stage distribution among COPD outpatients. Furthermore, we aimed to outline the COPD-related variables associated with referral for LC examination.Methods: We conducted a retrospective analysis encompassing the period from 1 January 2012 to 31 December 2018 on all outpatients with COPD and LC and individuals referred for LC examinations.Results: Among all COPD outpatients, 2231 patients (18%) were referred for LC examinations and 565 (4.6%) were diagnosed with LC. LC patients with COPD were more likely to be stage I–II, in contrast to the non-COPD LC population (46%versus26%, p2) and experienced a greater frequency of exacerbations (30%versus24% with two or more exacerbations).Conclusion: Our study revealed a notably high LC incidence among COPD outpatients. LC patients with COPD were diagnosed at earlier stages, and outpatients with more pronounced COPD symptoms were more inclined to undergo LC diagnostics. The overrepresentation of LC cases among COPD outpatients emphasises the importance of tailoring specific screening initiatives for this demographic.
- Open Access
Pulmonologists-Level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach
Lung cancer (LC) remains the primary cause of cancer-related mortality, largely due to late-stage diagnoses. Effective strategies for early detection are therefore of paramount importance. In recent years, machine learning (ML) has demonstrated considerable potential in healthcare by facilitating the detection of various diseases. In this retrospective development and validation study, we developed an ML model based on dynamic ensemble selection (DES) for LC detection. The model leverages standard blood sample analysis and smoking history data from a large population at risk in Denmark. The study includes all patients examined on suspicion of LC in the Region of Southern Denmark from 2009 to 2018. We validated and compared the predictions by the DES model with diagnoses provided by five pulmonologists. Among the 38,944 patients, 9,940 had complete data of which 2,505 (25\%) had LC. The DES model achieved an area under the roc curve of 0.77$\pm$0.01, sensitivity of 76.2\%$\pm$2.4\%, specificity of 63.8\%$\pm$2.3\%, positive predictive value of 41.6\%$\pm$1.2\%, and F\textsubscript{1}-score of 53.8\%$\pm$1.1\%. The DES model outperformed all five pulmonologists, achieving a sensitivity 9\% higher than their average. The model identified smoking status, age, total calcium levels, neutrophil count, and lactate dehydrogenase as the most important factors for the detection of LC. The results highlight the successful application of the ML approach in detecting LC, surpassing pulmonologists' performance. Incorporating clinical and laboratory data in future risk assessment models can improve decision-making and facilitate timely referrals.
Open AccessPulmonologists-Level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach
Lung cancer (LC) remains the primary cause of cancer-related mortality, largely due to late-stage diagnoses. Effective strategies for early detection are therefore of paramount importance. In recent years, machine learning (ML) has demonstrated considerable potential in healthcare by facilitating the detection of various diseases. In this retrospective development and validation study, we developed an ML model based on dynamic ensemble selection (DES) for LC detection. The model leverages standard blood sample analysis and smoking history data from a large population at risk in Denmark. The study includes all patients examined on suspicion of LC in the Region of Southern Denmark from 2009 to 2018. We validated and compared the predictions by the DES model with diagnoses provided by five pulmonologists. Among the 38,944 patients, 9,940 had complete data of which 2,505 (25\%) had LC. The DES model achieved an area under the roc curve of 0.77$\pm$0.01, sensitivity of 76.2\%$\pm$2.4\%, specificity of 63.8\%$\pm$2.3\%, positive predictive value of 41.6\%$\pm$1.2\%, and F\textsubscript{1}-score of 53.8\%$\pm$1.1\%. The DES model outperformed all five pulmonologists, achieving a sensitivity 9\% higher than their average. The model identified smoking status, age, total calcium levels, neutrophil count, and lactate dehydrogenase as the most important factors for the detection of LC. The results highlight the successful application of the ML approach in detecting LC, surpassing pulmonologists' performance. Incorporating clinical and laboratory data in future risk assessment models can improve decision-making and facilitate timely referrals.
- Open Access
- 1 December 2023
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 12 (12) , 2392-2411
A collection of multiregistry data on patients at high risk of lung cancer—a Danish retrospective cohort study of nearly 40,000 patients
Background: Lung cancer (LC) is the leading cause of cancer related deaths, and several countries are implementing screening programs. Risk models have been introduced to refine the LC screening criteria, but the use of real-world data for this task demands a robust data infrastructure and quality. In this retrospective cohort study, we aim to address the different relevant risk factors in terms of data sources, descriptive statistics, completeness and quality. Methods: Data on comorbidity, prescription medication, smoking history, consultations, symptoms, familial predispositions, exposures, laboratory data among others were collected for all patients examined on a risk of LC over a 10-year period in the Region of Southern Denmark. Data were delivered from the regional data warehouse as well as the Danish Lung Cancer Registry. Associations between LC and non-LC groups were examined through Chi-squared test (categorical variables) and Wilcoxon signed-rank test (continuous variables that were non-parametric). These associations were investigated on both the original datasets and the subset of patients with complete data. Results: The number of examined individuals increased over the study period and more patients were diagnosed with LC in stage I–II, from 18% in 2009 to 31% in 2018. LC patients were more likely to be older, smoker, with a registered prescription of the included medication. They also exhibited differences in laboratory analysis indicating inflammation and hyponatremia. Weight loss, fatigue and pain were more prevalent in the LC group, while hemoptysis and fever were more common among the non-LC patients. Advanced-stage LC patients experienced a higher rate of symptoms compared to those in the low stages. Within the sub-cohort with complete dataset results, most observed trends persisted, although data on comorbidities were susceptibility to change. Conclusions: This study provides key insights into LC risk assessment using a robust dataset of patients examined for suspected LC. A consistent positive trend in early-stage LC diagnosis was observed throughout the study period. LC patients exhibited distinct smoking behaviors, medication patterns, variations in lab results, and specific symptoms. These discoveries have the potential to enhance discrimination in machine learning-based prediction models, particularly those capable of handling complex distributions. Serving as a detailed account of real-world data collection and processing, the study establishes a foundation for future development of prediction models aimed at facilitating the early referral of LC patients.
- 1 December 2023
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 12 (12) , 2392-2411
Open AccessA collection of multiregistry data on patients at high risk of lung cancer—a Danish retrospective cohort study of nearly 40,000 patients
Background: Lung cancer (LC) is the leading cause of cancer related deaths, and several countries are implementing screening programs. Risk models have been introduced to refine the LC screening criteria, but the use of real-world data for this task demands a robust data infrastructure and quality. In this retrospective cohort study, we aim to address the different relevant risk factors in terms of data sources, descriptive statistics, completeness and quality. Methods: Data on comorbidity, prescription medication, smoking history, consultations, symptoms, familial predispositions, exposures, laboratory data among others were collected for all patients examined on a risk of LC over a 10-year period in the Region of Southern Denmark. Data were delivered from the regional data warehouse as well as the Danish Lung Cancer Registry. Associations between LC and non-LC groups were examined through Chi-squared test (categorical variables) and Wilcoxon signed-rank test (continuous variables that were non-parametric). These associations were investigated on both the original datasets and the subset of patients with complete data. Results: The number of examined individuals increased over the study period and more patients were diagnosed with LC in stage I–II, from 18% in 2009 to 31% in 2018. LC patients were more likely to be older, smoker, with a registered prescription of the included medication. They also exhibited differences in laboratory analysis indicating inflammation and hyponatremia. Weight loss, fatigue and pain were more prevalent in the LC group, while hemoptysis and fever were more common among the non-LC patients. Advanced-stage LC patients experienced a higher rate of symptoms compared to those in the low stages. Within the sub-cohort with complete dataset results, most observed trends persisted, although data on comorbidities were susceptibility to change. Conclusions: This study provides key insights into LC risk assessment using a robust dataset of patients examined for suspected LC. A consistent positive trend in early-stage LC diagnosis was observed throughout the study period. LC patients exhibited distinct smoking behaviors, medication patterns, variations in lab results, and specific symptoms. These discoveries have the potential to enhance discrimination in machine learning-based prediction models, particularly those capable of handling complex distributions. Serving as a detailed account of real-world data collection and processing, the study establishes a foundation for future development of prediction models aimed at facilitating the early referral of LC patients.